chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Shortness of breath/out of breath; Breathing very heavily as if I had been running; Nausea; My body was clammy all over; Blood pressure was 178/106; Tightness in my chest; Kept taking deep breaths, with an overall feeling of weakness; Feel unwell with cold like symptoms, including chills; Feel unwell with cold like symptoms, including chills; feel unwell with cold like symptoms, including chills; This is a spontaneous report from a contactable consumer or other non hcp. A 78-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 22Jan2021 (Batch/Lot Number: EL3302) at single dose for covid-19 immunisation. Medical history included Heart stent placed in 2016, high blood pressure, enlarged prostate. Concomitant medication included rivaroxaban (XARELTO); metoprolol; losartan; aspirin [acetylsalicylic acid]. The patient previously took finasteride, dutasteride and experienced Known allergies. It was reported that on 24Jan2021 00:15/12:15 AM patient had shortness of breath within 30 minutes of receiving the injection, and was breathing very heavily as if I had been running. By the time I got to the car, I was totally out of breath. Any slight exertion over the next week would bring this on. The day after the injection on the morning of 24Jan2021 I awakened with nausea, my body was clammy all over, Blood pressure was 178/106, tightness in my chest, and kept taking deep breaths, with an overall feeling of weakness. Went to the ER ,and was checked out and released after all tests were neg. for a heart problem. I continued to feel unwell with cold like symptoms, including chills. Adverse event treatment was emergency room protocol for a suspected heart attack, Patient did not had covid prior vaccination, Patient did not tested covid post vaccination. Outcome of the all events was recovering.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Decreased appetite, Fatigue, Feeling cold, Headache, Mobility decreased
Clinical narrative: I have had off and on chills; sometimes fever; body aches; fatigue; tiredness; can't sleep at night; This is a spontaneous report from a contactable Other HCP. A 44-years-old male patient received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EL3302; dose number=2) via an intramuscular on 01Feb2021 at 14:00 at single dose for Covid-19 immunization. Medical history included colitis ulcerative and gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing. Also, the patient had covid-19 prior to vaccination. The patient had allergy to erythromycin. The patient received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EN9581; dose number=1) via an intramuscular on 11Jan2021 at 14:00 at single dose for Covid-19 immunization. Concomitant medications included famotidine, finasteride and omeprazole. As per the adverse event description, on 02Feb2021 01:00 AM, the patient had off and on chills, sometimes fever, body aches, fatigue, tiredness since the second dose. He can't sleep at night, because each night around 2am, he woke up with severe chills. He probably have a fever, but don't tested himself. He took 800mg of Ibuprofen and within an hour to his chills break. That usually lasts till midafternoon. Then he get the chills again, take more ibuprofen and wait for bed. He usually an active person, but have been unable to work out since the shot. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nasal congestion, Nausea, Pain, Pyrexia
Clinical narrative: I have had off and on chills; sometimes fever; body aches; fatigue; tiredness; can't sleep at night; This is a spontaneous report from a contactable Other HCP. A 44-years-old male patient received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EL3302; dose number=2) via an intramuscular on 01Feb2021 at 14:00 at single dose for Covid-19 immunization. Medical history included colitis ulcerative and gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing. Also, the patient had covid-19 prior to vaccination. The patient had allergy to erythromycin. The patient received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EN9581; dose number=1) via an intramuscular on 11Jan2021 at 14:00 at single dose for Covid-19 immunization. Concomitant medications included famotidine, finasteride and omeprazole. As per the adverse event description, on 02Feb2021 01:00 AM, the patient had off and on chills, sometimes fever, body aches, fatigue, tiredness since the second dose. He can't sleep at night, because each night around 2am, he woke up with severe chills. He probably have a fever, but don't tested himself. He took 800mg of Ibuprofen and within an hour to his chills break. That usually lasts till midafternoon. Then he get the chills again, take more ibuprofen and wait for bed. He usually an active person, but have been unable to work out since the shot. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Insomnia, Pain, Pyrexia
Clinical narrative: I have had off and on chills; sometimes fever; body aches; fatigue; tiredness; can't sleep at night; This is a spontaneous report from a contactable Other HCP. A 44-years-old male patient received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EL3302; dose number=2) via an intramuscular on 01Feb2021 at 14:00 at single dose for Covid-19 immunization. Medical history included colitis ulcerative and gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing. Also, the patient had covid-19 prior to vaccination. The patient had allergy to erythromycin. The patient received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EN9581; dose number=1) via an intramuscular on 11Jan2021 at 14:00 at single dose for Covid-19 immunization. Concomitant medications included famotidine, finasteride and omeprazole. As per the adverse event description, on 02Feb2021 01:00 AM, the patient had off and on chills, sometimes fever, body aches, fatigue, tiredness since the second dose. He can't sleep at night, because each night around 2am, he woke up with severe chills. He probably have a fever, but don't tested himself. He took 800mg of Ibuprofen and within an hour to his chills break. That usually lasts till midafternoon. Then he get the chills again, take more ibuprofen and wait for bed. He usually an active person, but have been unable to work out since the shot. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Headache, Myalgia
Clinical narrative: fatigue; headache; muscle & joint aches; muscle & joint aches; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received second dose of BNT162B2 (BNT162B2, product: COVID 19, Pfizer- BIONTECH, Solution for injection, Lot number: 9269) via an unspecified route of administration, administered in Arm Left on 06Feb2021 10:30 as single dose for covid-19 immunisation. Medical history included hypertension (controlled) and irritable bowel syndrome. Known allergies was none. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), verapamil, spironolactone (ALDACTONE) and losartan all are via unspecified route from unspecified date at unspecified dose and frequency for unspecified indication. Facility type vaccine: Other, if other vaccine in four weeks, COVID prior vaccination and COVID tested post vaccination reported as no. historical vaccine included first dose of BNT162B2 product: COVID 19, Pfizer- BIONTECH, Lot number: 8982 on 16Jan2021: 02:00 PM unspecified route Left arm for COVID-19 immunization. The patient experienced fatigue, headache, muscle and joint aches on 06Feb2021 14:30. Patient received treatment for AE reported as no. The outcome of the events was resolved on an unspecified date in Feb2021.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia
Clinical narrative: fatigue; headache; muscle & joint aches; muscle & joint aches; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received second dose of BNT162B2 (BNT162B2, product: COVID 19, Pfizer- BIONTECH, Solution for injection, Lot number: 9269) via an unspecified route of administration, administered in Arm Left on 06Feb2021 10:30 as single dose for covid-19 immunisation. Medical history included hypertension (controlled) and irritable bowel syndrome. Known allergies was none. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), verapamil, spironolactone (ALDACTONE) and losartan all are via unspecified route from unspecified date at unspecified dose and frequency for unspecified indication. Facility type vaccine: Other, if other vaccine in four weeks, COVID prior vaccination and COVID tested post vaccination reported as no. historical vaccine included first dose of BNT162B2 product: COVID 19, Pfizer- BIONTECH, Lot number: 8982 on 16Jan2021: 02:00 PM unspecified route Left arm for COVID-19 immunization. The patient experienced fatigue, headache, muscle and joint aches on 06Feb2021 14:30. Patient received treatment for AE reported as no. The outcome of the events was resolved on an unspecified date in Feb2021.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Ear pain, Headache, Hyperhidrosis, Pain
Clinical narrative: arm pain at injection site; chills; sweats; body, head and ear aches; body, head and ear aches; body, head and ear aches; This is a spontaneous report from a contactable consumer (self reported). A 71-year-old male patient (consumer) received Second dose of BNT162B2 (pfizer-biontech covid-19 vaccine Formulation: Solution for injection, Lot number: EZ9269, brand: Pfizer) via unspecified route of administration in the arm left on 06Feb2021 at 10:15 at single dose for COVID-19 immunisation. Medical history included premature ventricular beat and known allergies Sensitivity to opioids. Concomitant medications included lisinopril at 10 mg, finasteride (PROPECIA) at 1mg and atorvastatin. The patient took historical vaccine first dose of BNT162B2 (lot number: lot number: EZ8982) on 16Jan2021 at 10:00 AM in left arm 71years for COVID-19 immunisation. Patient did not have any other vaccine in four weeks. At 12 hours, the patient experienced arm pain at injection site, chills and sweats, body, head and ear aches on 07Feb2021 01:00. At 24 hours, only chills and sweats had abated. At 36 hours body aches abated. At 48 hours no issues. No treatment reported. No covid prior to vaccination and covid tested post vaccination. The outcome of the event arm pain at injection site, Headache, Ear pain was resolved on 09Feb2021, while other events were recovered on 08Feb2021.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm pain at injection site; chills; sweats; body, head and ear aches; body, head and ear aches; body, head and ear aches; This is a spontaneous report from a contactable consumer (self reported). A 71-year-old male patient (consumer) received Second dose of BNT162B2 (pfizer-biontech covid-19 vaccine Formulation: Solution for injection, Lot number: EZ9269, brand: Pfizer) via unspecified route of administration in the arm left on 06Feb2021 at 10:15 at single dose for COVID-19 immunisation. Medical history included premature ventricular beat and known allergies Sensitivity to opioids. Concomitant medications included lisinopril at 10 mg, finasteride (PROPECIA) at 1mg and atorvastatin. The patient took historical vaccine first dose of BNT162B2 (lot number: lot number: EZ8982) on 16Jan2021 at 10:00 AM in left arm 71years for COVID-19 immunisation. Patient did not have any other vaccine in four weeks. At 12 hours, the patient experienced arm pain at injection site, chills and sweats, body, head and ear aches on 07Feb2021 01:00. At 24 hours, only chills and sweats had abated. At 36 hours body aches abated. At 48 hours no issues. No treatment reported. No covid prior to vaccination and covid tested post vaccination. The outcome of the event arm pain at injection site, Headache, Ear pain was resolved on 09Feb2021, while other events were recovered on 08Feb2021.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; Skin rash;Red tender swollen hot itchy rash developed at the injection site; Fatigue; Body aches; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in the left arm on 05Feb2021 12:15 (Batch/Lot Number: EL9269) as SINGLE DOSE for covid-19 immunization.  Patient had no other medical history. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included macrogol 3350 (MIRALAX) taken for an unspecified indication, start and stop date were not reported; OTC multivitamins and BCP.  Six (6) hours after injection, (05Feb 2021 18:15) patient experienced fatigue and body aches lasting less than 12 hours. On 13Feb2021 12:00, the patient experienced redness, swelling, pain at injection site lasting about 4 days. Delayed skin rash.  appeared starting on day 8 (13Feb2021 12:00), described as a red tender swollen hot itchy rash developed at the injection site. The outcome of events was reported as "not recovered". Patient did not receive any treatment due to these events.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; Skin rash;Red tender swollen hot itchy rash developed at the injection site; Fatigue; Body aches; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in the left arm on 05Feb2021 12:15 (Batch/Lot Number: EL9269) as SINGLE DOSE for covid-19 immunization.  Patient had no other medical history. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included macrogol 3350 (MIRALAX) taken for an unspecified indication, start and stop date were not reported; OTC multivitamins and BCP.  Six (6) hours after injection, (05Feb 2021 18:15) patient experienced fatigue and body aches lasting less than 12 hours. On 13Feb2021 12:00, the patient experienced redness, swelling, pain at injection site lasting about 4 days. Delayed skin rash.  appeared starting on day 8 (13Feb2021 12:00), described as a red tender swollen hot itchy rash developed at the injection site. The outcome of events was reported as "not recovered". Patient did not receive any treatment due to these events.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain, Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; Skin rash;Red tender swollen hot itchy rash developed at the injection site; Fatigue; Body aches; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in the left arm on 05Feb2021 12:15 (Batch/Lot Number: EL9269) as SINGLE DOSE for covid-19 immunization.  Patient had no other medical history. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included macrogol 3350 (MIRALAX) taken for an unspecified indication, start and stop date were not reported; OTC multivitamins and BCP.  Six (6) hours after injection, (05Feb 2021 18:15) patient experienced fatigue and body aches lasting less than 12 hours. On 13Feb2021 12:00, the patient experienced redness, swelling, pain at injection site lasting about 4 days. Delayed skin rash.  appeared starting on day 8 (13Feb2021 12:00), described as a red tender swollen hot itchy rash developed at the injection site. The outcome of events was reported as "not recovered". Patient did not receive any treatment due to these events.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site swelling
Clinical narrative: The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; The patient experienced redness, swelling, pain at injection site; Skin rash;Red tender swollen hot itchy rash developed at the injection site; Fatigue; Body aches; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in the left arm on 05Feb2021 12:15 (Batch/Lot Number: EL9269) as SINGLE DOSE for covid-19 immunization.  Patient had no other medical history. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included macrogol 3350 (MIRALAX) taken for an unspecified indication, start and stop date were not reported; OTC multivitamins and BCP.  Six (6) hours after injection, (05Feb 2021 18:15) patient experienced fatigue and body aches lasting less than 12 hours. On 13Feb2021 12:00, the patient experienced redness, swelling, pain at injection site lasting about 4 days. Delayed skin rash.  appeared starting on day 8 (13Feb2021 12:00), described as a red tender swollen hot itchy rash developed at the injection site. The outcome of events was reported as "not recovered". Patient did not receive any treatment due to these events.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Injection site pruritus, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: Very minor reaction localized to the injection site; the area is hot, swollen, with a few hives; the area is hot, swollen, with a few hives; the area is hot, swollen, with a few hives; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 13Feb2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. There was no medical history. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included sertraline and bupropion hydrochloride (WELLBUTRIN), both from unknown dates and unknown if ongoing for unknown indications. The patient also received unspecified combination birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced very minor reaction localized to the injection site and the area was hot, swollen, with a few hives on 20Feb2021 at 14:00. Symptoms only appeared 7 days after injection. The patient did not receive any treatment for the events. The clinical outcomes of very minor reaction localized to the injection site and the area was hot, swollen, with a few hives were recovering.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site reaction, Vaccination site swelling, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Very minor reaction localized to the injection site; the area is hot, swollen, with a few hives; the area is hot, swollen, with a few hives; the area is hot, swollen, with a few hives; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 13Feb2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. There was no medical history. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included sertraline and bupropion hydrochloride (WELLBUTRIN), both from unknown dates and unknown if ongoing for unknown indications. The patient also received unspecified combination birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced very minor reaction localized to the injection site and the area was hot, swollen, with a few hives on 20Feb2021 at 14:00. Symptoms only appeared 7 days after injection. The patient did not receive any treatment for the events. The clinical outcomes of very minor reaction localized to the injection site and the area was hot, swollen, with a few hives were recovering.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid, Diabetes mellitus, Dyspnoea, Nausea, Pharyngeal swelling
Clinical narrative: COVID Vaccine clinic. Per chart review, pt received COVID vaccine at 1426.   At approximately 1505 pt c/o nausea and ran outside.  Pt awake, alert, respirations easy and unlabored, no distress noted.  No vomiting occurred.  Pt stated history of throat swelling and facial swelling/rash after PCN.   1510: Pt stated nausea resolved.  Pt Diabetic and had not eaten lunch.  Juice and crackers given, pt tolerated well with no difficulty.  Respirations remain easy and unlabored, no distress.   1517: Pt clearing throat, c/o throat swelling, able to manage oral secretions, speaking in complete sentences.  Pt to triage area via wheelchair by RN. BP 171/80  | Pulse 77  | Resp 17  | LMP 02/01/2013 (LMP Unknown)  | SpO2 98%    1523: Pt awake, alert, c/o difficulty breathing.  RN called for assistance, attempted to located on site MDs.    1526: No MDs on site, 911 called. BP 184/84  | Pulse 82  | Resp 20  | LMP 02/01/2013 (LMP Unknown)  | SpO2 100%    1528: RN called ED MD, Dr., verbal order received for Epinephrine 0.3 mg subcutaneous one time now.   1530: Epinephrine given per MD order.   1532: EMS crew on scene, Sac City 7, assessing patient, full report given by RN.  During transfer of care, pt started shaking, full body, eyes closed, assisted to supine position on gurney by EMS crew, no injuries occurred, very short duration- pt aroused. Pt and her personal belongings to ED by EMS crew.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor, White blood cell count increased
Clinical narrative: COVID Vaccine clinic. Per chart review, pt received COVID vaccine at 1426.   At approximately 1505 pt c/o nausea and ran outside.  Pt awake, alert, respirations easy and unlabored, no distress noted.  No vomiting occurred.  Pt stated history of throat swelling and facial swelling/rash after PCN.   1510: Pt stated nausea resolved.  Pt Diabetic and had not eaten lunch.  Juice and crackers given, pt tolerated well with no difficulty.  Respirations remain easy and unlabored, no distress.   1517: Pt clearing throat, c/o throat swelling, able to manage oral secretions, speaking in complete sentences.  Pt to triage area via wheelchair by RN. BP 171/80  | Pulse 77  | Resp 17  | LMP 02/01/2013 (LMP Unknown)  | SpO2 98%    1523: Pt awake, alert, c/o difficulty breathing.  RN called for assistance, attempted to located on site MDs.    1526: No MDs on site, 911 called. BP 184/84  | Pulse 82  | Resp 20  | LMP 02/01/2013 (LMP Unknown)  | SpO2 100%    1528: RN called ED MD, Dr., verbal order received for Epinephrine 0.3 mg subcutaneous one time now.   1530: Epinephrine given per MD order.   1532: EMS crew on scene, Sac City 7, assessing patient, full report given by RN.  During transfer of care, pt started shaking, full body, eyes closed, assisted to supine position on gurney by EMS crew, no injuries occurred, very short duration- pt aroused. Pt and her personal belongings to ED by EMS crew.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Chest X-ray normal, Dyspnoea, Electrocardiogram normal, Nausea
Clinical narrative: COVID Vaccine clinic. Per chart review, pt received COVID vaccine at 1426.   At approximately 1505 pt c/o nausea and ran outside.  Pt awake, alert, respirations easy and unlabored, no distress noted.  No vomiting occurred.  Pt stated history of throat swelling and facial swelling/rash after PCN.   1510: Pt stated nausea resolved.  Pt Diabetic and had not eaten lunch.  Juice and crackers given, pt tolerated well with no difficulty.  Respirations remain easy and unlabored, no distress.   1517: Pt clearing throat, c/o throat swelling, able to manage oral secretions, speaking in complete sentences.  Pt to triage area via wheelchair by RN. BP 171/80  | Pulse 77  | Resp 17  | LMP 02/01/2013 (LMP Unknown)  | SpO2 98%    1523: Pt awake, alert, c/o difficulty breathing.  RN called for assistance, attempted to located on site MDs.    1526: No MDs on site, 911 called. BP 184/84  | Pulse 82  | Resp 20  | LMP 02/01/2013 (LMP Unknown)  | SpO2 100%    1528: RN called ED MD, Dr., verbal order received for Epinephrine 0.3 mg subcutaneous one time now.   1530: Epinephrine given per MD order.   1532: EMS crew on scene, Sac City 7, assessing patient, full report given by RN.  During transfer of care, pt started shaking, full body, eyes closed, assisted to supine position on gurney by EMS crew, no injuries occurred, very short duration- pt aroused. Pt and her personal belongings to ED by EMS crew.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Throat clearing, Tremor
Clinical narrative: COVID Vaccine clinic. Per chart review, pt received COVID vaccine at 1426.   At approximately 1505 pt c/o nausea and ran outside.  Pt awake, alert, respirations easy and unlabored, no distress noted.  No vomiting occurred.  Pt stated history of throat swelling and facial swelling/rash after PCN.   1510: Pt stated nausea resolved.  Pt Diabetic and had not eaten lunch.  Juice and crackers given, pt tolerated well with no difficulty.  Respirations remain easy and unlabored, no distress.   1517: Pt clearing throat, c/o throat swelling, able to manage oral secretions, speaking in complete sentences.  Pt to triage area via wheelchair by RN. BP 171/80  | Pulse 77  | Resp 17  | LMP 02/01/2013 (LMP Unknown)  | SpO2 98%    1523: Pt awake, alert, c/o difficulty breathing.  RN called for assistance, attempted to located on site MDs.    1526: No MDs on site, 911 called. BP 184/84  | Pulse 82  | Resp 20  | LMP 02/01/2013 (LMP Unknown)  | SpO2 100%    1528: RN called ED MD, Dr., verbal order received for Epinephrine 0.3 mg subcutaneous one time now.   1530: Epinephrine given per MD order.   1532: EMS crew on scene, Sac City 7, assessing patient, full report given by RN.  During transfer of care, pt started shaking, full body, eyes closed, assisted to supine position on gurney by EMS crew, no injuries occurred, very short duration- pt aroused. Pt and her personal belongings to ED by EMS crew.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood thyroid stimulating hormone, Condition aggravated, Dizziness, Electrocardiogram
Clinical narrative: Two minutes after given the vaccine at the time of 2:00 p.m. my heart rate dropped below 90, and I blacked out immediately about two minutes later.  Facility then transferred me hospital because I could not sit up without my heart spiking above 130 bpm. At hospital they kept me on bed rest, gave me fluids, Tylenol, and started to treat me because they speculate that the vaccine triggered the P.O.T.S. syndrome. I was at hospital from 03/12/2021 and was discharged Monday night 03/15/2021. I have not recovered from the event, and am not able to stand, walk, or sit up for a prolonged amount of time without feeling faint, dizzy, overheated, or lightheaded.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Full blood count, Hyperhidrosis, Metabolic function test, Pregnancy test
Clinical narrative: Two minutes after given the vaccine at the time of 2:00 p.m. my heart rate dropped below 90, and I blacked out immediately about two minutes later.  Facility then transferred me hospital because I could not sit up without my heart spiking above 130 bpm. At hospital they kept me on bed rest, gave me fluids, Tylenol, and started to treat me because they speculate that the vaccine triggered the P.O.T.S. syndrome. I was at hospital from 03/12/2021 and was discharged Monday night 03/15/2021. I have not recovered from the event, and am not able to stand, walk, or sit up for a prolonged amount of time without feeling faint, dizzy, overheated, or lightheaded.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Presyncope, Tachycardia, Thyroxine, Troponin
Clinical narrative: Two minutes after given the vaccine at the time of 2:00 p.m. my heart rate dropped below 90, and I blacked out immediately about two minutes later.  Facility then transferred me hospital because I could not sit up without my heart spiking above 130 bpm. At hospital they kept me on bed rest, gave me fluids, Tylenol, and started to treat me because they speculate that the vaccine triggered the P.O.T.S. syndrome. I was at hospital from 03/12/2021 and was discharged Monday night 03/15/2021. I have not recovered from the event, and am not able to stand, walk, or sit up for a prolonged amount of time without feeling faint, dizzy, overheated, or lightheaded.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dizziness postural, Feeling hot, Heart rate decreased, Heart rate increased
Clinical narrative: Two minutes after given the vaccine at the time of 2:00 p.m. my heart rate dropped below 90, and I blacked out immediately about two minutes later.  Facility then transferred me hospital because I could not sit up without my heart spiking above 130 bpm. At hospital they kept me on bed rest, gave me fluids, Tylenol, and started to treat me because they speculate that the vaccine triggered the P.O.T.S. syndrome. I was at hospital from 03/12/2021 and was discharged Monday night 03/15/2021. I have not recovered from the event, and am not able to stand, walk, or sit up for a prolonged amount of time without feeling faint, dizzy, overheated, or lightheaded.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Postural orthostatic tachycardia syndrome
Clinical narrative: Two minutes after given the vaccine at the time of 2:00 p.m. my heart rate dropped below 90, and I blacked out immediately about two minutes later.  Facility then transferred me hospital because I could not sit up without my heart spiking above 130 bpm. At hospital they kept me on bed rest, gave me fluids, Tylenol, and started to treat me because they speculate that the vaccine triggered the P.O.T.S. syndrome. I was at hospital from 03/12/2021 and was discharged Monday night 03/15/2021. I have not recovered from the event, and am not able to stand, walk, or sit up for a prolonged amount of time without feeling faint, dizzy, overheated, or lightheaded.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pharyngeal hypoaesthesia, Throat irritation
Clinical narrative: anaphylactic reaction, difficulty breathing, swollen throat, tight chest, confusion, flushing, weakness, numb tongue.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Asthenia, Chest discomfort, Confusional state, Dyspnoea
Clinical narrative: anaphylactic reaction, difficulty breathing, swollen throat, tight chest, confusion, flushing, weakness, numb tongue.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flushing, Hypoaesthesia oral, Pharyngeal swelling
Clinical narrative: anaphylactic reaction, difficulty breathing, swollen throat, tight chest, confusion, flushing, weakness, numb tongue.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Chest discomfort, Confusional state, Disorientation, Heart rate
Clinical narrative: anaphylactic reaction, difficulty breathing, swollen throat, tight chest, confusion, flushing, weakness, numb tongue.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Heart rate increased, Hypoaesthesia oral, Pharyngeal swelling, Swollen tongue
Clinical narrative: anaphylactic reaction, difficulty breathing, swollen throat, tight chest, confusion, flushing, weakness, numb tongue.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Shortly after receiving the vaccine my left arm in the elbow turned red and welts arose. I  received 2 doses of children's benedryl and after 10 or 15 minutes the adverse effects were better, less redness and welts subsiding
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Urticaria
Clinical narrative: Shortly after receiving the vaccine my left arm in the elbow turned red and welts arose. I  received 2 doses of children's benedryl and after 10 or 15 minutes the adverse effects were better, less redness and welts subsiding
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Chest discomfort, Dizziness, Headache, Pharyngeal swelling
Clinical narrative: Swelling, closed throat, burning in throat Chest pain Headache  Nausea
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Headache, Nausea, Oropharyngeal discomfort, Pharyngeal swelling
Clinical narrative: Swelling, closed throat, burning in throat Chest pain Headache  Nausea
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: Swelling, closed throat, burning in throat Chest pain Headache  Nausea
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Hyperhidrosis, Pallor, Throat tightness
Clinical narrative: Minutes after receiving the first dose of the Moderna vaccine, patient complained of difficulty breathing.  I asked if she was wheezing and she said no.  A doctor in the clinic came over and even though it wasn't time for patient and her sister to leave (based on 15-minutes after receiving the vaccine) he initially suggested that they might be fine to go, but after patient told him of her symptoms and at my urging he decided to have her stay a little longer.   I think it was at this time that he had someone check her pulse.  I don't know what the pulse reading was.  He stepped away and shortly afterwards patient started complaining that her throat felt strange and was making it hard to breathe.  The doctor immediately came back over, found patient was having difficulty breathing and holding herself upright in the chair.  I held her by the shoulders to keep her from falling while the doctor also steadied her and asked a worker in the room for an epi-pen.  The worker didn't seem to react much to the request so he told her louder that he needed an epi-pen.  She started searching her area and the doctor started yelling across the room to others that he needed an epi-pen.  It seemed like others initially took the demand less urgently than they should, but eventually someone came with an epi-pen.  By this time I don't think patient was very conscious, if at all.  Sometime during this time the doctor also instructed someone to call 911.  The doctor tried using the epi-pen but at first he had some kind of cap on it that prevented it from working.  He removed the cap and not finding an easy way to have a sterilized injection site he injected the epi-pen through patient's jeans.  Soon afterwards a cot was brought out and workers had me step aside as they took patient and put her on the cot.  Patient seemed to gradually become more aware of her surroundings and it wasn't long before she appeared to me to be fully conscious once again.  They checked her blood pressure and pulse and maybe did other tests during this time.  Eventually the ambulance arrived and patient was very clear with everyone that she did not want to incur the expenses of riding in the ambulance and I offered to bring her wherever they suggested that she should go.  They watched and evaluated her for a while and eventually had her sign the form declining the ambulance transportation.  They suggested that she make an appointment with her doctor but did not suggest that we take patient to an emergency room.  We departed and patient did not afterward  seem to experience any symptoms from the vaccine other than some of the general feelings of being sick, soreness at the injection site, etc. that others report with the Moderna vaccine.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Injection site pain, Loss of consciousness, Malaise, Oropharyngeal discomfort
Clinical narrative: Minutes after receiving the first dose of the Moderna vaccine, patient complained of difficulty breathing.  I asked if she was wheezing and she said no.  A doctor in the clinic came over and even though it wasn't time for patient and her sister to leave (based on 15-minutes after receiving the vaccine) he initially suggested that they might be fine to go, but after patient told him of her symptoms and at my urging he decided to have her stay a little longer.   I think it was at this time that he had someone check her pulse.  I don't know what the pulse reading was.  He stepped away and shortly afterwards patient started complaining that her throat felt strange and was making it hard to breathe.  The doctor immediately came back over, found patient was having difficulty breathing and holding herself upright in the chair.  I held her by the shoulders to keep her from falling while the doctor also steadied her and asked a worker in the room for an epi-pen.  The worker didn't seem to react much to the request so he told her louder that he needed an epi-pen.  She started searching her area and the doctor started yelling across the room to others that he needed an epi-pen.  It seemed like others initially took the demand less urgently than they should, but eventually someone came with an epi-pen.  By this time I don't think patient was very conscious, if at all.  Sometime during this time the doctor also instructed someone to call 911.  The doctor tried using the epi-pen but at first he had some kind of cap on it that prevented it from working.  He removed the cap and not finding an easy way to have a sterilized injection site he injected the epi-pen through patient's jeans.  Soon afterwards a cot was brought out and workers had me step aside as they took patient and put her on the cot.  Patient seemed to gradually become more aware of her surroundings and it wasn't long before she appeared to me to be fully conscious once again.  They checked her blood pressure and pulse and maybe did other tests during this time.  Eventually the ambulance arrived and patient was very clear with everyone that she did not want to incur the expenses of riding in the ambulance and I offered to bring her wherever they suggested that she should go.  They watched and evaluated her for a while and eventually had her sign the form declining the ambulance transportation.  They suggested that she make an appointment with her doctor but did not suggest that we take patient to an emergency room.  We departed and patient did not afterward  seem to experience any symptoms from the vaccine other than some of the general feelings of being sick, soreness at the injection site, etc. that others report with the Moderna vaccine.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: Not feeling really good; Face and my back started stinking and itching real bad; Face and my back started stinking and itching real bad; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9809; Expiration Date: Jun2023), via an unspecified route of administration on 09Feb2021 SINGLE DOSE for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient reported that, "I got my first Pfizer shot on Tuesday the 9th and about 4 hours after I got the shot my face and my back started stinking and itching real bad and I called my doctor and he said try Benadryl so I took Benadryl (expiry date reported for Benadryl: Jun2023) and it made it worse and I called the doctor back again today he said well he do not know if that is the side effect to the shot or not. So, I should ask you guys to see if that is." It was further probed/ clarified and the consumer reported that, "Well I am not feeling really good right now. We just have to find."The outcome of the events was unknown.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Pruritus, Skin odour abnormal
Clinical narrative: Not feeling really good; Face and my back started stinking and itching real bad; Face and my back started stinking and itching real bad; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9809; Expiration Date: Jun2023), via an unspecified route of administration on 09Feb2021 SINGLE DOSE for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient reported that, "I got my first Pfizer shot on Tuesday the 9th and about 4 hours after I got the shot my face and my back started stinking and itching real bad and I called my doctor and he said try Benadryl so I took Benadryl (expiry date reported for Benadryl: Jun2023) and it made it worse and I called the doctor back again today he said well he do not know if that is the side effect to the shot or not. So, I should ask you guys to see if that is." It was further probed/ clarified and the consumer reported that, "Well I am not feeling really good right now. We just have to find."The outcome of the events was unknown.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Burning sensation, Pain of skin, Pruritus, Skin burning sensation
Clinical narrative: Not feeling really good; Face and my back started stinking and itching real bad; Face and my back started stinking and itching real bad; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9809; Expiration Date: Jun2023), via an unspecified route of administration on 09Feb2021 SINGLE DOSE for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient reported that, "I got my first Pfizer shot on Tuesday the 9th and about 4 hours after I got the shot my face and my back started stinking and itching real bad and I called my doctor and he said try Benadryl so I took Benadryl (expiry date reported for Benadryl: Jun2023) and it made it worse and I called the doctor back again today he said well he do not know if that is the side effect to the shot or not. So, I should ask you guys to see if that is." It was further probed/ clarified and the consumer reported that, "Well I am not feeling really good right now. We just have to find."The outcome of the events was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Flushing, Hypertension
Clinical narrative: Brain felt fuzzy. Weak. Hands shaking. Heart pounding. blood pressure went up to 181 over 106 had to quickly lay on the floor until paramedics arrived.  I was taken to hospital.  Took 2 hours to feel well enough to go home.  I slept most of 2 days. Tiredness comes and goes.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood pressure increased, Blood test, Electrocardiogram, Fatigue
Clinical narrative: Brain felt fuzzy. Weak. Hands shaking. Heart pounding. blood pressure went up to 181 over 106 had to quickly lay on the floor until paramedics arrived.  I was taken to hospital.  Took 2 hours to feel well enough to go home.  I slept most of 2 days. Tiredness comes and goes.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Palpitations, Tremor
Clinical narrative: Brain felt fuzzy. Weak. Hands shaking. Heart pounding. blood pressure went up to 181 over 106 had to quickly lay on the floor until paramedics arrived.  I was taken to hospital.  Took 2 hours to feel well enough to go home.  I slept most of 2 days. Tiredness comes and goes.
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chills, Dyskinesia, Nausea
Clinical narrative: Pt described spasms/jerking motions in hands, arms, legs and feet from approximaely 9p - 4a tge night of her vaccination
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Dyskinesia, Muscle spasms
Clinical narrative: Pt described spasms/jerking motions in hands, arms, legs and feet from approximaely 9p - 4a tge night of her vaccination
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chills, Dyskinesia, Tremor
Clinical narrative: Pt described spasms/jerking motions in hands, arms, legs and feet from approximaely 9p - 4a tge night of her vaccination
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Oral pruritus, Throat irritation, Tongue pruritus
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Flushed / Sweating-Mild
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Hyperhidrosis, Pruritus
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Flushed / Sweating-Mild
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Insomnia
Clinical narrative: Insomnia as if I had a caffeine high. I never have a problem falling asleep. I was up all night. My head didn't feel right but it wasn't a headache.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash erythematous, Rash pruritic
Clinical narrative: After 8 days a large red, itchy rash developed around the site of the injection on the left arm.